Pyridoxine-dependent epilepsy (PDE) is identified as a rare neurometabolic disease marked by biallelic pathogenic mutations of the ALDH7A1 gene. The gene discussed is ALDH7A1; the disease is pyridoxine-dependent epilepsy.